Literature DB >> 15236013

Pulmonary hypertensive response to declamping of the aorta during abdominal aortic reconstructive surgery-role of metabolic derangement and anaphylatoxin in the reaction.

M Wakamatsu1, Y Minamoto, F Okumura.   

Abstract

Metabolic parameters and anaphylatoxin activities in mixed venous blood were measured in 16 patients undergoing abdominal aortic reconstructive surgery to study the mechanism of pulmonary hypertensive response after aortic declamping. This reaction was confirmed by a rise in ratio between mean pulmonary arterial pressure and mean systemic arterial pressure (Pp/Ps). Aortic declamping was followed by a significant increase in lactate level and lactate-pyruvate ratio (L/P ratio) as compared with pre-declamping level ( P << 0.01). Although anaphylatoxin C3a concentration rose significantly after declamping ( P << 0.01), C5a showed no change at any stage. When the patients were divided into two groups according to the degree of Pp/Ps change by declamping, significant elevation of L/P ratio and C3a level were observed in the group with higher increase (Post-/Pre-declamp value >/=1.25) of Pp/Ps compared to the lower (>>1.25) group. After declamping, in the higher Pp/Ps group, a positive correlation existed not only between Pp/Ps change and aortic clamp time, but also between L/P ratio and C3a level. The present results suggest that muscular metabolic derangement distal to the aortic clamp may play an important role in the development of post-declamping pulmonary hypertensive response through anaphylatoxin C3a.

Entities:  

Year:  1990        PMID: 15236013     DOI: 10.1007/s0054000040029

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  14 in total

1.  Noncardiogenic pulmonary edema after abdominal aortic aneurysm surgery.

Authors:  I S Paterson; J M Klausner; R Pugatch; P Allen; J A Mannick; D Shepro; H B Hechtman
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

2.  Rise in pulmonary arterial pressure following release of aortic crossclamp in abdominal aortic aneurysmectomy.

Authors:  M Kainuma; K Nishiwaki; Y Shimada
Journal:  Anesthesiology       Date:  1988-08       Impact factor: 7.892

3.  Complement and anaphylatoxin responses to cross-clamping of the aorta. Studies during general anaesthesia with or without extradural blockade.

Authors:  A Bengtson; W Lannsjö; M Heideman
Journal:  Br J Anaesth       Date:  1987-09       Impact factor: 9.166

4.  The influence of periaortic collateral vessels on the intraoperative hemodynamic effects of acute aortic occlusion in patients with aorto-occlusive disease or abdominal aortic aneurysm.

Authors:  W E Johnston; F J Balestrieri; G Plonk; V D'Souza; G Howard
Journal:  Anesthesiology       Date:  1987-03       Impact factor: 7.892

5.  Leukotriene synthesis and receptor blockers block hypoxic pulmonary vasoconstriction.

Authors:  M L Morganroth; J T Reeves; R C Murphy; N F Voelkel
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-05

6.  Influence of mixed venous oxygen tension (PVO2) on blood flow to atelectatic lung.

Authors:  K B Domino; L Wetstein; S A Glasser; L Lindgren; C Marshall; A Harken; B E Marshall
Journal:  Anesthesiology       Date:  1983-11       Impact factor: 7.892

7.  Metabolic changes in blood and skeletal muscle in reconstructive aortic surgery.

Authors:  J Andersson; B Eklöf; P Neglén; D Thomson
Journal:  Ann Surg       Date:  1979-03       Impact factor: 12.969

Review 8.  Myocardial ischemia: the pathogenesis of irreversible cell injury in ischemia.

Authors:  J L Farber; K R Chien; S Mittnacht
Journal:  Am J Pathol       Date:  1981-02       Impact factor: 4.307

9.  Prostacyclin and thromboxane A2 synthesis by rabbit pulmonary artery.

Authors:  P M Salzman; J A Salmon; S Moncada
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

10.  Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.

Authors:  F Marceau; T E Hugli
Journal:  J Pharmacol Exp Ther       Date:  1984-09       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.